Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 171

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Anti-inflammatory properties of the μ opioid receptor support its use in the treatment of colon inflammation

Open access
Philippe, David, Dubuquoy, Laurent, Groux, Hervé, Brun, Valérie, Chuoï-Mariot, Myriam Tran Van, Gaveriaux-Ruff, Claire, Colombel, Jean-Frédéric, Kieffer, Brigitte L., Desreumaux, Pierre · 2003 · Journal of Clinical Investigation

Abstract

The physiologic role of the mu opioid receptor (MOR) in gut nociception, motility, and secretion is well established. To evaluate whether MOR may also be involved in controlling gut inflammation, we first showed that subcutaneous administration of selective peripheral MOR agonists, named DALDA and DAMGO, significantly reduces inflammation in two experimental models of colitis induced by administration of 2,4,6-trinitrobenzene sulfonic acid (TNBS) or peripheral expansion of CD4(+) T cells in mice. This therapeutic effect was almost completely abolished by concomitant administration of the opioid antagonist naloxone. Evidence of a genetic role for MOR in the control of gut inflammation was provided by showing that MOR-deficient mice were highly susceptible to colon inflammation, with a 50% mortality rate occurring 3 days after TNBS administration. The mechanistic basis of these observations suggests that the anti-inflammatory effects of MOR in the colon are mediated through the regulation of cytokine production and T cell proliferation, two important immunologic events required for the development of colon inflammation in mice and patients with inflammatory bowel disease (IBD). These data provide evidence that MOR plays a role in the control of gut inflammation and suggest that MOR agonists might be new therapeutic molecules in IBD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci16750

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 171

Metadata

Authors
Philippe, D., Dubuquoy, L., Groux, H., Brun, V., Chuoï-Mariot, M. T. V., Gaveriaux-Ruff, C., Colombel, J.-F., Kieffer, B. L., & Desreumaux, P.
Venue
Journal of Clinical Investigation
Published
2003-05-01
Volume
111
Issue
9
Pages
1329-1338
ISSN
0021-9738 (ISSN-L)
OpenAlex
W1994597071
Cited by
171
References
6
FWCI
3.11
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Anti-inflammatory properties of the μ opioid receptor support its use in the treatment of colon inflammation. https://app.cochat.ai/papers/10.1172/jci16750
The paper
Philippe, D., Dubuquoy, L., Groux, H., Brun, V., Chuoï-Mariot, M. T. V., Gaveriaux-Ruff, C., Colombel, J.-F., Kieffer, B. L., & Desreumaux, P. (2003). Anti-inflammatory properties of the μ opioid receptor support its use in the treatment of colon inflammation. Journal of Clinical Investigation. https://doi.org/10.1172/jci16750

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.